glp 1 overview GLP-1 actions and target organs. GLP-1, through its receptor GLP-1R, A Comprehensive Review of the

These findings highlight the importance of maintaining continuous GLP-1 treatment to sustain cardiovascular benefits and indicate that strategies to reduce treatment discontinuity should be developed to maximize the cardioprotective effects of GLP-1s

Low adherence to GLP-1 drugs could limit long-term mortality benefits

A randomized, controlled trial of 3.0 mg of Liraglutide in weight management

Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among Obese commercially insured adults without diabetes

Moreover, they are resistant to DPP-4 activity and have a longer half-life than native GLP-1